Iron biomarkers, including ferritin, transferrin saturation, soluble transferrin receptor (sTfR), hepcidin and EPO levels, were measured at baseline.<h4>Results</h4>Over a median 18.5 year follow-up, 1090 participants developed cancer. This evidence concerns the gene EPO and cancer.